Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Experimental and Clinical Psychopharmacology
|
March 4, 2021
Compounded intranasal racemic ketamine for major depressive disorder: A case report
Lindsey Ziegler, Evyn Peters, Annabelle Wanson, et al.
The Mental Health Clinician
|
October 13, 2025
Clozapine rechallenge after clozapine-induced myocarditis: A case report to validate a previously published protocol
Sara J Russell, Matthew Josdal, Annabelle Wanson, et al.
Experimental and Clinical Psychopharmacology
|
December 8, 2022
Intranasal racemic ketamine for patients hospitalized with treatment-resistant depression: A retrospective analysis
Evyn M Peters, Katelyn Halpape, Isaac Cheveldae, et al.
Canadian Family Physician Medecin De Famille Canadien
|
May 13, 2021
Japheth Bool, Alex Crawley, Annabelle Wanson, et al.
The Mental Health Clinician
|
April 14, 2021
Opioid toxicity due to CNS depressant polypharmacy: A case report
Christine Lee, Annabelle Wanson, Sarah Frangou, et al.
Canadian Family Physician Medecin De Famille Canadien
|
May 13, 2021
Pharmacotherapy management of schizophrenia for family physicians
Japheth Bool, Alex Crawley, Annabelle Wanson, et al.
BMC Psychiatry
|
January 8, 2025
Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant depression: a naturalistic feasibility study
Katelyn Halpape, Raelle Pashovitz, Annabelle Wanson, et al.
The Mental Health Clinician
|
December 22, 2023
Intranasal ketamine as a treatment for psychiatric complications of long COVID: A case report
Kaitlyn Baldwin, Annabelle Wanson, Lee-Anne Gilecki, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
|
June 29, 2025
Bridging the mind and body: exploring venous thromboembolism in psychiatric inpatients
Ryan R D Chan, Emma Hamid, Thuy Le, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Experimental and Clinical Psychopharmacology
|
March 4, 2021
Compounded intranasal racemic ketamine for major depressive disorder: A case report
Lindsey Ziegler, Evyn Peters, Annabelle Wanson, et al.
The Mental Health Clinician
|
October 13, 2025
Clozapine rechallenge after clozapine-induced myocarditis: A case report to validate a previously published protocol
Sara J Russell, Matthew Josdal, Annabelle Wanson, et al.
Experimental and Clinical Psychopharmacology
|
December 8, 2022
Intranasal racemic ketamine for patients hospitalized with treatment-resistant depression: A retrospective analysis
Evyn M Peters, Katelyn Halpape, Isaac Cheveldae, et al.
Canadian Family Physician Medecin De Famille Canadien
|
May 13, 2021
Japheth Bool, Alex Crawley, Annabelle Wanson, et al.
The Mental Health Clinician
|
April 14, 2021
Opioid toxicity due to CNS depressant polypharmacy: A case report
Christine Lee, Annabelle Wanson, Sarah Frangou, et al.
Canadian Family Physician Medecin De Famille Canadien
|
May 13, 2021
Pharmacotherapy management of schizophrenia for family physicians
Japheth Bool, Alex Crawley, Annabelle Wanson, et al.
BMC Psychiatry
|
January 8, 2025
Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant depression: a naturalistic feasibility study
Katelyn Halpape, Raelle Pashovitz, Annabelle Wanson, et al.
The Mental Health Clinician
|
December 22, 2023
Intranasal ketamine as a treatment for psychiatric complications of long COVID: A case report
Kaitlyn Baldwin, Annabelle Wanson, Lee-Anne Gilecki, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
|
June 29, 2025
Bridging the mind and body: exploring venous thromboembolism in psychiatric inpatients
Ryan R D Chan, Emma Hamid, Thuy Le, et al.
Page
of 1